PERCEPTIVE ADVISORS LLC Q3 2018 Filing

Filed November 14, 2018

Portfolio Value

$3.7T

Holdings

115

Report Date

Q3 2018

Filing Type

13F-HR

All Holdings (115 positions)

#StockSharesValue% PortfolioType
101
NTRANATERA INC
24,000$575.0M0.02%
102
SENS1GBPSENSEONICS HLDGS INC
115,000$549.0M0.01%
103
BLFSBIOLIFE SOLUTIONS INC
29,376$514.0M0.01%
104
ADAMIS PHARMACEUTICALS CORP
137,500$481.0M0.01%
105
MDGLMADRIGAL PHARMACEUTICALS INC
2,213$474.0M0.01%
106
PROTEON THERAPEUTICS INC
240,488$469.0M0.01%
107
IMMUNOMEDICS INC
21,335$444.0M0.01%
108
PERNIX THERAPEUTICS HLDGS IN
1,000,000$413.0M0.01%
109
VCELVERICEL CORP
27,211$385.0M0.01%
110
VACCINEX INC
50,000$365.0M0.01%
111
HCMHUTCHISON CHINA MEDITECH LTD
10,000$322.0M0.01%
112
CASI PHARMACEUTICALS INC
43,682$204.0M0.01%
113
ONCOSEC MED INC
50,000$70.0M0.00%
114
ONCOBIOLOGICS INC
420,875$6.0M0.00%
115
CAPRICOR THERAPEUTICS INC
4,000$4.0M0.00%
PreviousPage 2 of 2